Options Corner: Viking Therapeutics Sees Financial Giants Take Bullish Stance
Options Corner: Viking Therapeutics Sees Financial Giants Take Bullish Stance
Financial giants have made a conspicuous bullish move on Viking Therapeutics. Our analysis of options history for $Viking Therapeutics (VKTX.US)$ revealed 27 unusual trades.
金融巨头对Viking Therapeutics采取了明显的看涨举动。我们对期权历史的分析 $Viking Therapeutics (VKTX.US)$ 透露了27笔不寻常的交易。
Delving into the details, we found 48% of traders were bullish, while 44% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $142,317, and 24 were calls, valued at $1,477,692.
深入研究细节,我们发现48%的交易者看涨,而44%的交易者表现出看跌倾向。在我们发现的所有交易中,有3笔是看跌期权,价值为142,317美元,24笔是看涨期权,价值1,477,692美元。
Projected Price Targets
预计价格目标
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $20.0 and $115.0 for Viking Therapeutics, spanning the last three months.
在评估了交易量和未平仓合约之后,很明显,主要市场走势者将注意力集中在Viking Therapeutics在过去三个月中20.0美元至115.0美元之间的价格区间上。
Analyzing Volume & Open Interest
分析交易量和未平仓合约
In terms of liquidity and interest, the mean open interest for Viking Therapeutics options trades today is 1418.18 with a total volume of 16,148.00.
就流动性和利息而言,今天Viking Therapeutics期权交易的平均未平仓合约为1418.18,总交易量为16,148.00。
In the following chart, we are able to follow the development of volume and open interest of call and put options for Viking Therapeutics's big money trades within a strike price range of $20.0 to $115.0 over the last 30 days.
在下图中,我们可以跟踪过去30天Viking Therapeutics在20.0美元至115.0美元行使价区间内的大额资金交易的看涨期权和未平仓合约的发展情况。
Viking Therapeutics Option Activity Analysis: Last 30 Days
Viking Therapeutics 期权活动分析:过去 30 天
Biggest Options Spotted:
发现的最大选择:
Symbol |
PUT/CALL |
Trade Type |
Sentiment |
Exp. Date |
Ask |
Bid |
Price |
Strike Price |
Total Trade Price |
Open Interest |
Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
VKTX |
CALL |
SWEEP |
BULLISH |
06/21/24 |
$6.6 |
$6.5 |
$6.6 |
$75.00 |
$209.2K |
1.5K |
601 |
VKTX |
CALL |
SWEEP |
BEARISH |
05/17/24 |
$10.0 |
$8.7 |
$8.7 |
$65.00 |
$132.2K |
2.8K |
330 |
VKTX |
CALL |
SWEEP |
BEARISH |
09/20/24 |
$6.3 |
$6.1 |
$6.2 |
$100.00 |
$124.0K |
381 |
201 |
VKTX |
CALL |
SWEEP |
BULLISH |
06/21/24 |
$6.6 |
$6.5 |
$6.6 |
$75.00 |
$110.2K |
1.5K |
117 |
VKTX |
CALL |
SWEEP |
BEARISH |
01/17/25 |
$21.3 |
$19.7 |
$20.12 |
$70.00 |
$100.9K |
742 |
0 |
符号 |
看跌/看涨 |
交易类型 |
情绪 |
Exp。日期 |
问 |
出价 |
价格 |
行使价 |
总交易价格 |
未平仓合约 |
音量 |
---|---|---|---|---|---|---|---|---|---|---|---|
VKTX |
打电话 |
扫 |
看涨 |
06/21/24 |
6.6 美元 |
6.5 美元 |
6.6 美元 |
75.00 美元 |
209.2 万美元 |
1.5K |
601 |
VKTX |
打电话 |
扫 |
粗鲁的 |
05/17/24 |
10.0 美元 |
8.7 美元 |
8.7 美元 |
65.00 美元 |
132.2 万美元 |
2.8K |
330 |
VKTX |
打电话 |
扫 |
粗鲁的 |
09/20/24 |
6.3 美元 |
6.1 美元 |
6.2 美元 |
100.00 美元 |
124.0K |
381 |
201 |
VKTX |
打电话 |
扫 |
看涨 |
06/21/24 |
6.6 美元 |
6.5 美元 |
6.6 美元 |
75.00 美元 |
110.2 万美元 |
1.5K |
117 |
VKTX |
打电话 |
扫 |
粗鲁的 |
01/17/25 |
21.3 美元 |
19.7 美元 |
20.12 美元 |
70.00 美元 |
100.9 万美元 |
742 |
0 |
About Viking Therapeutics
关于维京疗法
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Viking Therapeutics Inc是一家医疗保健服务提供商。该公司专门从事以代谢和内分泌失调为重点的生物药品开发领域。该公司的临床项目管道包括 VK2809、VK5211、VK0214 产品。VK2809 和 VK0214 是可口服的甲状腺激素受体 β 的组织和受体亚型选择性激动剂。VK5211 是一种口服的非甾体选择性雄激素受体调节剂。
Following our analysis of the options activities associated with Viking Therapeutics, we pivot to a closer look at the company's own performance.
在分析了与Viking Therapeutics相关的期权活动之后,我们将转向仔细研究公司自身的业绩。
Viking Therapeutics's Current Market Status
Viking Therapeutics的当前市场状况
Currently trading with a volume of 2,266,930, the VKTX's price is up by 4.23%, now at $71.77.
RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
Anticipated earnings release is in 89 days.
VKTX目前的交易量为2,266,930美元,价格上涨了4.23%,目前为71.77美元。
RSI读数表明,该股目前在超买和超卖之间处于中立状态。
预计收益将在89天后发布。
Professional Analyst Ratings for Viking Therapeutics
Viking Therapeutics的专业分析师评级
In the last month, 1 experts released ratings on this stock with an average target price of $90.0.
上个月,1位专家发布了该股的评级,平均目标价为90.0美元。
An analyst from HC Wainwright & Co. has revised its rating downward to Buy, adjusting the price target to $90.
HC Wainwright & Co. 的一位分析师已将其评级下调至买入,将目标股价调整为90美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
与仅交易股票相比,期权是一种风险更高的资产,但它们具有更高的获利潜力。严肃的期权交易者通过每天自我教育、扩大交易规模、关注多个指标以及密切关注市场来管理这种风险。